Just returning from a Sickle Cell conference at the National Institute of Health in Bethesda, MD and am awl of the number of new clinical trials in the pipeline to develop new medicines to treat and cure Sickle Cell Disease. Over the years, I witnessed having just a few medications to treat the horrible complications persons experience from the damage causes from the 'sickling' of the
blood cells such as lung damage, heart enlargement and damage, kidney damage, joint and bone damage and etc.
The FDA recently approved new Drug called, Endari aimed to reduce sickling of the red blood cells. Although we are waiting for access to this medication, there is real hope on the Horizon. There are also new Point of Care testing trials to rapidly diagnose people with sickle cell and trait and even in non-invasive 'no needle' stick methods.
To find out more about these new therapies, visit a
Comprehensive Sickle Cell Treatment Center in your area.
Specialty Care Matters!
Click this link to read the TOVA Press Release on Endari
Join TOVA for the 6th Annual Sickle Cell 5K Run/Walk on September 30th
at Brandywine Zoo. Registration Opens at 9am and Race begins promptly
at 10am. Register at www.races2run.com
TOVA Community Health
Sickle Cell Specialty Treatment Center
213 Greenhill Ave., Suite B
Wilmington, DE 19805
(302) 429-5870 ext. 120-p
www.tovacommunityhealth.org
All the best, Dr. Nina
